We are live on
!
Find out more
T
Tahithromos Portfolio holdings
AUM
$71.9M
1-Year Est. Return
0.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
-0.24%
3 Year Est. Return
+16.44%
5 Year Est. Return
+53.61%
10 Year Est. Return
–
AUM
$416M
AUM Growth
-$30.1M
(-6.8%)
Cap. Flow
-$41.3M
Cap. Flow
% of AUM
-9.93%
Top 10 Holdings %
Top 10 Hldgs %
56.18%
Holding
45
New
9
Increased
15
Reduced
10
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHS
Chicos FAS, Inc.
CHS
|
+$17.7M |
| 2 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$13M |
| 3 |
VVUS
Vivus Inc
VVUS
|
+$9.42M |
| 4 |
Eagle Materials
EXP
|
+$7.41M |
| 5 |
HCA Healthcare
HCA
|
+$5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MBIA
MBI
|
+$16.9M |
| 2 |
X
US Steel
X
|
+$16.5M |
| 3 |
General Motors
GM
|
+$11.7M |
| 4 |
Community Health Systems
CYH
|
+$10.6M |
| 5 |
UNT
UNIT Corporation
UNT
|
+$9.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 26.86% |
| 2 | Healthcare | 25.77% |
| 3 | Industrials | 18.15% |
| 4 | Materials | 8.52% |
| 5 | Consumer Discretionary | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALJ
26
DELISTED
Alon USA Energy Inc
ALJ
| $3.2M | 0.77% |
214,426
-3,000
| -1% | -$45.3K |
|
|
NAV
27
DELISTED
Navistar International
NAV
| $2.9M | 0.7% |
+85,505
| New | +$3.02M |
|
28
Delek US
DK
$4.15B
| $2.88M | 0.69% |
99,000
| – | – |
|
29
Forestar Group
FOR
$1.47B
| $2.68M | 0.64% |
150,551
+3,112
| +2% | +$60.6K |
|
30
Dr. Reddy's Laboratories
RDY
$9.85B
| $2.19M | 0.53% |
+250,000
| New | +$2.17M |
|
|
WG
31
DELISTED
Willbros Group
WG
| $2.06M | 0.49% |
163,115
-259,226
| -61% | -$2.48M |
|
32
Calumet Specialty Products
CLMT
$3.81B
| $2M | 0.48% |
+77,514
| New | +$2.12M |
|
|
33
Community Health Systems
CYH
$391M
| $1.61M | 0.39% |
49,635
-320,954
| -87% | -$10.6M |
|
34
PUT
iShares Russell 2000 ETF
IWM
$80.2B
| $911K | 0.22% |
+4,856
| New | +$560K |
|
35
IDT Corp
IDT
$1.64B
| $732K | 0.18% |
+62,214
| New | +$756K |
|
36
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $705K | 0.17% |
+4,902
| New | +$900K |
|
|
AGIG
37
Abundia Global Impact Group
AGIG
$41.4M
| $265K | 0.06% |
3,847
| – | – |
|
|
EMKR
38
DELISTED
Emcore Corp
EMKR
| $93K | 0.02% |
+1,843
| New | +$91.4K |
|
|
39
General Motors
GM
$80B
| – | – |
-286,896
| Closed | -$11.7M |
|
|
40
MBIA
MBI
$274M
| – | – |
-1,411,471
| Closed | -$16.9M |
|
41
Meta Platforms (Facebook)
META
$1.37T
| – | – |
-55,000
| Closed | -$3.01M |
|
42
Nabors Industries
NBR
$1.22B
| – | – |
-7,957
| Closed | -$6.76M |
|
|
X
43
DELISTED
US Steel
X
| – | – |
-559,329
| Closed | -$16.5M |
|
|
PES
44
DELISTED
Pioneer Energy Services Corp.
PES
| – | – |
-1,076,430
| Closed | -$8.62M |
|
|
BV
45
DELISTED
Bazaarvoice, Inc.
BV
| – | – |
-1,176,995
| Closed | -$9.32M |
|
Similar funds
GC
DCM
XS
SCM
BSCP
FMA
MSTVIM
LA
Tahithromos's Q1 2014 Portfolio in Review
As of Q1 2014, Tahithromos held 45 positions worth $416M, down 6.8% from $446M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Tahithromos withdrew a net $41.3M in Q1 2014, closing 7 positions and reducing 10 holdings. Its most notable exit was MBIA, an estimated $16.9M position sold in full.
By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 32% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Tahithromos opened a new position in Veradigm Inc. Common Stock worth $13.5M.
- Tahithromos's largest Q1 2014 buy was Veradigm Inc. Common Stock: 751,098 shares worth $13.5M.
- Tahithromos added most to Chicos FAS, Inc. in Q1 2014, an estimated $17.7M increase.
- Tahithromos's biggest Q1 2014 reduction was Community Health Systems, cutting an estimated $10.6M.
- Tahithromos fully exited MBIA in Q1 2014, selling an estimated $16.9M.
- Tahithromos's ten largest holdings make up 56% of its $416M portfolio in Q1 2014.
- Tahithromos opened 9 new positions and closed 7 in Q1 2014.
- Tahithromos's portfolio value fell 6.8% quarter-over-quarter to $416M.
Based on Tahithromos's 13F filing for Q1 2014, filed 2 May 2014.